Pharmaceutical care has become an important part of the management of asthma and chronic obstructive pulmonary disease (COPD). There is evidence for its role in improving adherence, optimizing pharmacotherapy and improving clinical outcomes, as confirmed by a recent meta-analysis.
Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich
Jetzt beitreten
Jetzt beitreten
Already a member? Log in here
